The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 01, 2022
Filed:
Nov. 28, 2018
Applicant:
Kalvista Pharmaceuticals Limited, Wiltshire, GB;
Inventors:
John Herman Collett, Flintshire, GB;
Gary Paul Cook, Westford, MA (US);
Jamie Joseph Farrar, Flintshire, GB;
Michael John Frodsham, Flintshire, GB;
Michael Bryan Roe, Wiltshire, GB;
Richard Simon Todd, Wiltshire, GB;
Robert Neil Ward, Flintshire, GB;
Assignee:
KalVista Pharmaceuticals Limited, Porton Down, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/48 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); C07D 401/14 (2006.01); A61K 9/00 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 9/4858 (2013.01); A61K 9/1652 (2013.01); A61K 9/2054 (2013.01); A61K 9/2853 (2013.01); A61K 9/4891 (2013.01); C07D 401/14 (2013.01); A61K 9/0053 (2013.01); A61K 45/06 (2013.01); C07B 2200/13 (2013.01);
Abstract
The present invention relates to oral solid dosage forms comprising a plasma kallikrein inhibitor, in particular a solid form (Form 1) of the compound of Formula A. Also provided are methods of preparing oral solid dosage forms comprising the compound of Formula A using Form 1 of the compound of Formula A.